CCND1 and glioblastoma: Intriguingly, upon EGF receptor activation, PKM2 binds histone H3 and phosphorylates histone H3 at T11, resulting in the acetylation of histone H3 at K9 to activate CCND1 and MYC expression in glioblastoma cells [21].